Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDMTR.L Regulatory News (DMTR)

  • There is currently no data for DMTR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

23 May 2022 07:00

RNS Number : 3481M
DeepMatter Group PLC
23 May 2022
 

23 May 2022

 

Alan Aubrey appointed Chairman of DeepMatter

 

DeepMatter Group Plc (AIM: DMTR, "Deepmatter", the "Group"), the digital chemistry data and software company, announces the appointment of Alan Aubrey as non-executive Chairman after the AGM on the 27 May 2022. He takes over from Karen Bach, who is retiring from the board and leaving the Group.

 

Alan has a successful 20-year track record in founding, developing, and growing disruptive technology businesses. He co-founded Techtran Limited in 2002, which was acquired in 2005 by IP Group Plc, a company that develops world-changing science and technology businesses across life sciences, technology and cleantech. Alan was appointed IP Group's CEO shortly after the acquisition and he went on to lead the business to become a member of the FTSE 250.

 

Alan brings significant experience to the Group in the commercialisation of science and the creation of high growth technology businesses that address global markets. Amongst other businesses, Alan has served on the boards of high-profile technology businesses such as Oxford Nanopore Technologies plc and Ceres Power Holdings Plc. He contributed to the growth of dozens of businesses in the life sciences, manufacturing and sustainability industries.

 

Alan is currently non-executive chairman of OxCCU Limited, an Oxford University spin-out focused using CO₂ and renewable energy to make sustainable fuels, chemicals and plastics. He also is a director of both Trellix Limited and Rio AI Limited, which are applying Artificial Intelligence to address business problems.

 

Alan is a Chartered Accountant and from 1995-2001, was a corporate finance partner in KPMG. 

 

Alan is subscribing for 200,000,000 new ordinary shares in the Group at a price of 0.1p per share, prior to his starting date. A further announcement in relation to the subscription will be issued in due course.

Alan currently holds 7,311,393 ordinary shares representing 0.19 per cent of the total voting rights in the Company.

Mark Warne, Chief Executive of DeepMatter, said:

 

"On behalf of everyone at Deepmatter, I would like to thank Karen for her valued contribution and support over the last 20 months which sees the business well positioned for the market opportunity ahead of it. We are delighted that Alan will join us as we enter the next phase of growth."

 

Karen Bach, Chair of Deepmatter said:

 

"Over the past 20 months the Group has built a great team and established the building blocks to commercialise both data and technology. I am proud of the progress we made in this early commercialisation phase. The business has an exciting delivery phase ahead and I wish the team well."

 

Alan Aubrey, Chairman-designate of DeepMatter, commented:

 

"I am joining Deepmatter at a very exciting and dynamic time. Chemistry touches all our lives but the research and development of new chemical formulae remains relatively unsophisticated.

 

"Our vision is to build the capabilities for scientists to access and exploit vast amounts of chemical reaction data. Our SmartChemistry™ platform provides easy access and exploitation of the data in order to make chemical reaction discovery and design faster, safer, more efficient and increasingly sustainable. The recently announced multi-year SmartChemistry™ contracts with Standigm and Springer Nature are evidence of this."

 

For more information contact

 

DeepMatter Group Plc Fraser Benson, Chief Financial Officer 0141 548 8156

Canaccord Genuity Limited (Nominated Advisor and Broker) 020 7523 8000Bobbie Hilliam

Meare Consulting 07990 858548Adrian Duffield

About DeepMatter Group plc 

 

DeepMatter's SmartChemistry™ platform enables scientists across a range of industries, including pharma, biotech, agri-science, scientific publishers and contract research organisations (CROs), to easily capture, access and exploit the vast amounts of data created in chemical reactions.

 

DeepMatter integrates its proprietary chemistry data and proprietary software to significantly improve productivity, efficiency, discovery, safety and sustainability of chemical reactions for its customers.

 

DeepMatter's SmartChemistry™ platform capitalises on the combination of its cloud technology, low cost-sensors, connectivity to laboratory hardware and high-performance computing trends such as artificial intelligence (AI).

 

Visit: www.deepmatter.io and follow @deepmattergroup

 

 

As required under Schedule Two, paragraph (g) of the AIM Rules for Companies, further disclosures on Mr Aubrey are as follows:

 

Mr Alan John Aubrey, aged 61, has held the following directorships and/or partnerships in the past five years:

 

Current directorships and/or partnerships:

IP2IPO Services Limited

Rio Al Limited

Trellix Limited

EUREKA! THE NATIONAL CHILDREN'S MUSEUM

Redcentric plc (effective 22 July 2022)

 

 

 

Past directorships and/or partnerships:

· Top Technology Ventures Limited

· IP Assist Services Limited

· IP2IPO Asia-Pacific Limited

· IP2IPO Innovations Limited

· IP2IPO Limited

· LifeUK (IP2IPO) Limited

· IP Ventures (Scotland) Limited

· IP Industry Partners Limited

· IP2IPO ANZ Carry Limited

· Avacta Group Plc

· IP Group Plc

· MOBILIOn Inc

· Oxford Nanopore Technologies Plc

· IP2IPO Guarantee Limited

· Oxford Science Enterprises Plc

· IP2IPO Management VI Limited

· Proactis Holdings Plc

· IP2IPO Management V Limited

· Ceres Power Intermediate Holdings Limited

· IP2IPO (Europe) Limited

· Ceres Power Holdings Plc

· IP2IPO Management IV Limited

· North East Technology (GP) Limited

· IP Venture Fund (GP) Limited

· Touchstone Innovations Limited

· IP2IPO Management II Limited

· IP2IPO Company Maker Limited

· IP2IPO Management Limited

· IP2IPO US Partners Limited

· Innovations Limited Partner Ltd

· IP2IPO Americas Limited

· Touchstone Innovations Investments Limited

 

There is no further information on Mr Aubrey required to be disclosed under Schedule Two, paragraph (g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAPPUPWAUPPGBP
Date   Source Headline
13th Apr 20167:00 amRNSPreliminary Results
21st Oct 20157:00 amRNSCompletion of Capital Reorganisation
7th Oct 20151:56 pmRNSResult of Court Hearing
29th Sep 20153:33 pmRNSHolding(s) in Company
28th Sep 201510:02 amRNSHolding(s) in Company
16th Sep 20157:00 amRNSChange of Name
15th Sep 20153:32 pmRNSHolding(s) in Company
15th Sep 201510:02 amRNSDirectors' Interest in Shares
15th Sep 201510:01 amRNSDirectorate Changes
15th Sep 201510:00 amRNSCompletion of Placing and Acquisition
11th Sep 201510:00 amRNSApplication for Admission
10th Sep 201511:16 amRNSResult of General Meeting
25th Aug 20155:10 pmRNSHalf Yearly Report
25th Aug 20155:05 pmRNSAcquisition and related matters
7th Jul 20157:00 amRNSChange of Name
30th Jun 201512:10 pmRNSResult of AGM
4th Jun 20158:35 amRNSReplacement: Final Results
4th Jun 20157:00 amRNSDirectorate Change
4th Jun 20157:00 amRNSFinal Results
8th Jan 20155:56 pmRNSHolding(s) in Company
9th Sep 20147:00 amRNSCompletion of investment in subsidiary
29th Aug 20147:00 amRNSHalf Yearly Report
14th Jul 201411:00 amRNSResult of AGM
30th Jun 20147:00 amRNSFirst commercial sale
17th Jun 20147:00 amRNSFinal Results
17th Mar 20147:00 amRNSGraphene Functionalisation Capabilities
3rd Feb 20147:00 amRNSProject Announcement
24th Jan 20147:00 amRNSOAS launches OntoTM Development Pack for customer
18th Nov 20135:43 pmRNSHolding(s) in Company
30th Oct 20137:00 amRNSDirectorate Change
18th Oct 20137:00 amRNSChange to substantial shareholdings
20th Sep 20137:00 amRNSDirectorate Change
28th Aug 20139:40 amRNSHalf Yearly Report
13th Jun 20135:30 pmRNSAGM Statement
1st May 20137:00 amRNSFinal Results
12th Apr 20131:10 pmRNSHolding(s) in Company
13th Mar 20138:42 amRNSHolding(s) in Company
12th Mar 20138:37 amRNSHolding(s) in Company
6th Mar 20134:03 pmRNSHolding(s) in Company
9th Jan 20137:00 amRNSTechnical Advisory Board Enhanced
7th Jan 20134:25 pmRNSHolding(s) in Company
20th Dec 20121:55 pmRNSHolding(s) in Company
5th Dec 20125:33 pmRNSHolding(s) in Company
12th Nov 20128:51 amRNSHolding(s) in Company
3rd Oct 20127:00 amRNSDirectors' Interest in Shares
26th Sep 20127:00 amRNSInterim Statement
24th Sep 20129:58 amRNSHolding(s) in Company
17th Sep 20129:26 amRNSHolding(s) in Company
1st Aug 20127:00 amRNSAppointment of CEO
15th Jun 201212:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.